Error-corrected duplex sequencing enables direct detection and quantification of mutations in human TK6 cells with strong inter-laboratory consistency
- PMID: 37491114
- PMCID: PMC10395007
- DOI: 10.1016/j.mrgentox.2023.503649
Error-corrected duplex sequencing enables direct detection and quantification of mutations in human TK6 cells with strong inter-laboratory consistency
Abstract
Error-corrected duplex sequencing (DS) enables direct quantification of low-frequency mutations and offers tremendous potential for chemical mutagenicity assessment. We investigated the utility of DS to quantify induced mutation frequency (MF) and spectrum in human lymphoblastoid TK6 cells exposed to a prototypical DNA alkylating agent, N-ethyl-N-nitrosourea (ENU). Furthermore, we explored appropriate experimental parameters for this application, and assessed inter-laboratory reproducibility. In two independent experiments in two laboratories, TK6 cells were exposed to ENU (25-200 µM) and DNA was sequenced 48, 72, and 96 h post-exposure. A DS mutagenicity panel targeting twenty 2.4-kb regions distributed across the genome was used to sample diverse, genome-representative sequence contexts. A significant increase in MF that was unaffected by time was observed in both laboratories. Concentration-response in the MF from the two laboratories was strongly positively correlated (r = 0.97). C:G>T:A, T:A>C:G, T:A>A:T, and T:A>G:C mutations increased in consistent, concentration-dependent manners in both laboratories, with high proportions of C:G>T:A at all time points. The consistent results across the three time points suggest that 48 h may be sufficient for mutation analysis post-exposure. The target sites responded similarly between the two laboratories and revealed a higher average MF in intergenic regions. These results, demonstrating remarkable reproducibility across time and laboratory for both MF and spectrum, support the high value of DS for characterizing chemical mutagenicity in both research and regulatory evaluation.
Keywords: Error-corrected next-generation sequencing; In vitro; Mutagenesis; Mutation spectrum; N-ethyl-N-nitrosourea.
Crown Copyright © 2023. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest EC, CDS, MR, AW, CLY, FM, LR, KLW, and SLSR declare that they have no conflict of interest. EKS, JY, THS, PV, FYL, CCV, and JJS are employees and equity holders at TwinStrand Biosciences, Inc. and are authors on one or more duplex sequencing-related patents.
Figures
References
-
- OECD, Test No. 476: In Vitro Mammalian Cell Gene Mutation Tests using the Hprt and xprt genes, in: Paris, France, 2016.
-
- OECD, Test No. 490: In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene, OECD Publishing, Paris, France, 2016.
-
- OECD, Test No. 471: Bacterial Reverse Mutation Test, in: OECD Publishing, Paris, France, 2020.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
